Venrock Associates IV L P, 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 285,714 shares at $0.70 ($200K) on 2019-01-23, disclosed to the SEC on 2019-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.70 | 142,857 | $100K | 50.0% |
| 2 | $0.70 | 142,857 | $100K | 50.0% |
| Total | $0.70 avg | 285,714 | $200K | 100% |